An Intranasal Vaccine Based on Outer Membrane Vesicles Against SARS-CoV-2

The prevailing pandemic of SARS-CoV-2 highlights the desperate need of alternative vaccine-platforms, which are safe, effective, and can be modified to carry antigens of emerging pathogens. The current SARS-CoV-2 vaccines based on mRNA and adenoviral vector technology meet some of these criteria but...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Himadri B. Thapa, Anna M. Müller, Andrew Camilli, Stefan Schild
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
RBD
Acceso en línea:https://doaj.org/article/f3db165878514641bd9bcc7d26aa6cf4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!